These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2055558)

  • 1. Fibrinolytic studies in 13 unrelated families with factor XII deficiency.
    Rodeghiero F; Castaman G; Ruggeri M; Cazzavillan M; Ferracin G; Dini E
    Haematologica; 1991; 76(1):28-32. PubMed ID: 2055558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor XII-dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- and kallikrein-dependent plasminogen proactivator.
    Kluft C; Trumpi-Kalshoven MM; Jie AF; Veldhuyzen-Stolk EC
    Thromb Haemost; 1979 Jun; 41(4):756-73. PubMed ID: 483248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor XII-induced fibrinolysis. Diminished proactivator activity and drastic reduction of activator activity in Fletcher factor-deficient plasma gamma globulin.
    Espana F; Aznar J; Estelles A
    J Lab Clin Med; 1982 Nov; 100(5):756-70. PubMed ID: 6182261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of intrinsic fibrinolysis in human plasma induced by dextran sulfate.
    Tsuda H; Miyata T; Iwanaga S; Yamamoto T
    Thromb Haemost; 1992 Apr; 67(4):440-4. PubMed ID: 1631792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic plasma fibrinolysis: involvement of urokinase-related activity in the factor XII-independent plasminogen proactivator pathway.
    Kluft C; Wijngaards G; Jie AF
    J Lab Clin Med; 1984 Mar; 103(3):408-19. PubMed ID: 6199446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contact system dependent fibrinolytic activity in vivo: observations in healthy subjects and factor XII deficient patients.
    Levi M; Hack CE; de Boer JP; Brandjes DP; Büller HR; ten Cate JW
    Agents Actions Suppl; 1992; 38 ( Pt 2)():292-8. PubMed ID: 1462834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of factor XII-dependent plasminogen proactivator in prekallikrein-deficient plasma.
    Bouma BN; Griffin JH
    J Lab Clin Med; 1978 Jan; 91(1):148-55. PubMed ID: 73563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo.
    Levi M; Hack CE; de Boer JP; Brandjes DP; Büller HR; ten Cate JW
    J Clin Invest; 1991 Oct; 88(4):1155-60. PubMed ID: 1833421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous type I plasminogen deficiency.
    Mingers AM; Heimburger N; Zeitler P; Kreth HW; Schuster V
    Semin Thromb Hemost; 1997; 23(3):259-69. PubMed ID: 9255907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboembolism and bleeding tendency in congenital factor XII deficiency--a study on 74 subjects from 14 Swiss families.
    Lämmle B; Wuillemin WA; Huber I; Krauskopf M; Zürcher C; Pflugshaupt R; Furlan M
    Thromb Haemost; 1991 Feb; 65(2):117-21. PubMed ID: 1905067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kallikrein and prekallikrein levels in a large number of congenital clotting deficiencies and abnormalities.
    Patrassi GM; Martinelli S; Vianello C; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(4):644-54. PubMed ID: 6184289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein.
    Binnema DJ; Dooijewaard G; Turion PN
    Thromb Haemost; 1991 Feb; 65(2):144-8. PubMed ID: 1905069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen--levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator.
    Jespersen J; Kluft C
    Thromb Haemost; 1985 Aug; 54(2):454-9. PubMed ID: 2417350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Congenital deficiency of factor Xii and spontaenous venous thrombosis treated with urokinase].
    Cornudella R; Moreno JA; Aguado MJ; Ansó V; Revilla JM; Calvo MT; Gutiérrez M
    Sangre (Barc); 1995 Jun; 40(3):219-22. PubMed ID: 7570275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro.
    Tanaka A; Suzuki Y; Sugihara K; Kanayama N; Urano T
    Life Sci; 2009 Jul; 85(5-6):220-5. PubMed ID: 19500599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic study in patients with factor XII deficiency: a report of three new mutations exon 13 (Q501STOP), exon 14 (P547L) and -13C>T promoter region in three compound heterozygotes.
    Lombardi AM; Bortoletto E; Scarparo P; Scapin M; Santarossa L; Girolami A
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):639-43. PubMed ID: 18832903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hageman-factor-dependent fibrinolysis: generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen.
    Mandle RJ; Kaplan AP
    Blood; 1979 Oct; 54(4):850-62. PubMed ID: 89876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.